Health Trials

Biliary Tract or Colorectal Cancer With Her2-positive/Mutated

1

Review clinical trials related to Biliary Tract or Colorectal Cancer With Her2-positive/Mutated. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.

To evaluate the efficacy and safety of SPH5030 tablets in subjects with Her2-positive/mutated biliary tract OR colorectal cancer.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Pharmaceuticals Holding Co., LtdUpdated: Aug 17, 2025Locations: 30
Eligibility criteria

Metastatic and/or unresectable advanced colorectal adenocarcinoma, or locally ad... [+7]

Subjects who have previously received anti-HER2 molecular targeted therapy; [+2]

Read more